Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

NICE (UK National Institute for Clinical Excellence) consults on confidential enquiries reform:

This article was originally published in Clinica

Executive Summary

The National Institute for Clinical Excellence (NICE) has issued proposals to reform the national confidential enquiries process. The document proposes "wide-ranging and challenging" changes to the remit, organisational structure and methodology of the enquiries, with the aim of giving the recommendations arising from them a similar status as other NICE guidance. NICE received responsibility for the four current enquiries, including the national confidential enquiry into perioperative deaths (NCEPOD) - in 1999. The enquiries aim to improve clinical practice through the investigation of deaths in specific circumstances. The full consultation document is available on the NICE website (www.nice.org.uk). The deadline for responses is October 31 2001.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT072370

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel